BDBM801001 US12590070, Compound 14::adamantan-1-yl)oxy)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)-N,3-dimethylbenzamide

SMILES CNC(=O)c1cccc(C)c1Nc1nc(Nc2ccc(O[C@]34CC5CC(C3)[C@@H](N3CC[C@H](NC(C)=O)C3)C(C5)C4)cc2OC)ncc1C(F)(F)F

InChI Key InChIKey=XZYMBUDXLSBVBD-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 801001   

TargetFocal adhesion kinase 1(Human)
Samjin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 801001BDBM801001(adamantan-1-yl)oxy)-2-methoxyphenyl)amino)-5-(trif...)
Affinity DataIC50: 57nMAssay Description:The inhibitory activity of the adamantane derivative compounds of the present invention to FAK, Pyk2 and InsR was confirmed through a biochemical kin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/10/2026
Entry Details
US Patent